Roxiper

Medicinal product

(Invented) name

Roxiper

Active substance (s)

Rozuvastatinas/tert-butilamino perindoprilis/Indapamidas

Strength

20 mg/8 mg/2,5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C10BX13, Rosuvastatin, perindopril and indapamide

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2019-12-03

Date of renewal

Documents

1131_1132_1133_1134_Roxiper_2022-12-20.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

tabletėje yra	1 vnt.
Rozuvastatinas	20 mg
tert-butilamino perindoprilis	8 mg
Indapamidas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102907	89008	1089008	lizdinė plokštelė	N30		Receptinis	LT/L/19/1134/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2019-12-03	Registruotas